ADMA BIOLOGICS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

ADMA BIOLOGICS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $510.17 million for the year ending 2025.

  • ADMA BIOLOGICS, INC. showed an increase of +19.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), ADMA BIOLOGICS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 1,108.4%.
  • Historical annual values: Fiscal year 2025: $510.17 million | Fiscal year 2024: $426.45 million | Fiscal year 2023: $258.22 million | Fiscal year 2022: $154.08 million | Fiscal year 2021: $80.94 million | Fiscal year 2020: $42.22 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: